Our research in humans demonstrated that genetic variants in IL6R was associated with a recurrence of AF after ablation, and these results support the idea that inflammation, especially the IL6–IL6R pathway, has important effects on the risk of AF recurrence after ablation. Here, IL6R is linked to atrial fibrillation.